Tomasz J. Guzik - Concepedia

Author

Tomasz J. Guzik

Also Known As

A. Gottsater, Antonio L. Dans, Diederick Grobbee, Dirk J Duncker, Guzik, Tomasz J, Humphreys, B.D., Robert Gropler, T GUZIK, T Guzik, T J Guzik

480

Publications

36.6K

Citations

H-Index

161

Concepts

All Affiliations

Jagiellonian University University of Glasgow University of Edinburgh John Radcliffe Hospital University of Oxford

About

Tomasz J. Guzik is an author at Jagiellonian University specializing in medicine, physiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	54	8.5K
2	Public Health	11	12	772
3	Health Sciences	8	8	1.1K
4	Allergy	4	4	1.4K
5	Engineering	1	1	12

Tomasz J. Guzik

146

Publications

23.2K

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, New England Journal of Medicine	2017	2.3K
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction Tomasz J. Guzik, Nyssa E. Hoch, Kathryn Brown, The Journal of Experimental Medicine	2007	1.7K
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options Tomasz J. Guzik, Saidi Mohiddin, Anthony Dimarco, Cardiovascular Research	2020	1.5K
Nitric oxide and superoxide in inflammation and immune regulation. Tomasz J. Guzik, Ryszard Korbut, T Adamek-Guzik PubMed No ConcentrationNitric OxideLipid PeroxidationImmune RegulationImmunology	2003	1.1K
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus Tomasz J. Guzik, Shafi Mussa, Daniela Gastaldi, Circulation	2002	975
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction Meena S. Madhur, Heinrich E. Lob, Louise McCann, Hypertension	2009	803
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Vascular Superoxide Production by NAD(P)H Oxidase Tomasz J. Guzik, Nick E.J. West, Edward Black, Circulation Research	2000	561
DC isoketal-modified proteins activate T cells and promote hypertension Annet Kirabo, Vanessa Fontana, Ana Paula de Faria, Journal of Clinical Investigation HypertensionDendritic CellT-regulatory CellImmunologyRenal Inflammation	2014	522

Page 1